Metabonomics: Metabolic processes studied by NMR spectroscopy of biofluids

Concepts in Magnetic Resonance

Volumn 12, Issue 5, 2000, Pages 289-320

  Lindon, John C ^{a,c,d,e,f,g,h}   Nicholson, Jeremy K ^a,i   Holmes, Elaine ^a,i   Everett, Jeremy R ^b,h,j,k,l  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b PFIZER GLOBAL RESEARCH AND DEVELOPMENT   (United Kingdom)

^c UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^d Och Spine at New York Presbyterian Hospitals   (United States)

^e UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^f WELLCOME RESEARCH LABORATORIES   (United Kingdom)

^g Spectroscopy Section   (United Kingdom)

^h GLAXOSMITHKLINE   (United Kingdom)

ⁱ UNIVERSITY OF LONDON   (United Kingdom)

^j UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^k MCMASTER UNIVERSITY   (Canada)

^l MCGILL UNIVERSITY   (Canada)

more..

Author keywords

Biofluids; Chemometrics; Classification; Disease; Metabolites; Metabonomics; NMR spectroscopy; Pattern recognition; Toxicity

Indexed keywords

EID: 0034368580     PISSN: 10437347     EISSN: None     Source Type: Journal    
DOI: 10.1002/1099-0534(2000)12:5<289::AID-CMR3>3.0.CO;2-W     Document Type: Article

References (93)

1. Gygi SP, Rochon Y, Franza BR, Aebersold R. Correlation between protein and mRNA abundance in yeast. Molec and Cellular Biol 1999; 19:1720-1730.
2. Klenk HP, et al. The complete genome sequence of the hyperthermophilic, sulphate-reducing archaeon Archaeoglobus fulgidus. Nature 1997; 390:364-370.
3. Geisow MJ. Proteomics: One small step for a digital computer, one giant leap for humankind. Nature Biotechnology 1998; 16:206.
4. Moka D, Spraul M, Nicholson JK, Foxall, PJD, Lindon JC. Biochemical classification of kidney carcinoma biopsy samples using magic angle spinning NMR spectroscopy. J Pharm Biomed Anal 1998; 17:125-132.
5. 1H NMR analysis of intact prostatic hyperplastic and tumour tissues. Anal Comm 1998; 35:113-115.
6. Sharaf MA, Illman DL, Kowalski BR. Chemometrics. New York: John Wiley & Sons; 1986. 332 p.
7. Nicholson JK, Wilson ID. High resolution proton magnetic resonance spectroscopy of biological fluids. Prog NMR Spectrosc 1989; 21:449-501.
8. 13C NMR spectroscopy of human blood plasma. Anal Chem 1995; 67:793-811.
9. Lindon JC, Nicholson JK, Everett JR. NMR spectroscopy of biofluids, In: Webb GA, editor. Annual reports on NMR spectroscopy. London: Academic Press; 1999. Vol 38, p 1-88.
10. Fan TW-M. Metabolite profiling by one- and two-dimensional NMR analysis of complex mixtures. Prog NMR Spectrosc 1996; 28:161-219.
11. Sze DY, Jardetzky O. High-resolution proton NMR studies of lymphocyte extracts. Immunomethods 1994; 4:113-126.
12. 2H-formate in urine as an indicator of microbiological contamination. J Pharm Biomed Anal 1993; 11:169-172.
13. 1H n.m.r. studies of vertebrate blood and plasma. Biochem J 1983; 211:605-615.
14. 2 relaxation agents for water suppression in spin-echo proton nuclear magnetic resonance spectroscopy of biological fluids. Anal Chem 1987; 59:2885-2891.
15. 1H NMR spectroscopy. J Magn Reson Anal 1996; 2:66-74.
16. Kriat M, Confort-Gouny S, Vion-Dury J, Sciaky M, Viout P, Cozzone PJ. Quantitation of metabolites in human blood serum by proton magnetic resonance spectroscopy. A comparative study of the use of formate and TSP as concentration standards. NMR in Biomed 1992; 5:179-184.
17. Bell JD, Brown JCC, Sadler PJ. NMR studies of body fluids. NMR in Biomed 1989; 2:246-256.
18. Grootveld M, Claxson AWD, Chander CL, Haycock P, Blake DR, Hawkes GE. High resolution proton NMR investigations of rat blood plasma. FEBS Letters 1993; 322:266-276.
19. Nicholson JK, O'Flynn MP, Sadler PJ, MacLeod AF, Juul SM, Sonksen PH. Proton nuclear magnetic resonance studies of serum, plasma and urine from fasting normal and diabetic subjects. Biochem J 1984; 217:365-375.
20. 1H NMR studies of human blood plasma. FEBS Letters 1987; 219:239-243.
21. Foxall PJD, Parkinson JA, Sadler IH, Lindon JC, Nicholson JK. Analysis of biological fluids using 600 MHz proton NMR spectroscopy: application of homonuclear two-dimensional J-resolved spectroscopy to urine and blood plasma for spectral simplification and assignment. J Pharm Biomed Anal 1993; 11:21-31.
22. Bell JD, Brown JCC, Kubal G, Sadler PJ. NMR-invisible lactate in blood plasma. FEBS Letters 1988; 235:81-86.
23. 1H NMR spectroscopy. J Pharm Biomed Anal 1993; 11:897-902.
24. Stilbs PJ. Fourier transform pulsed-gradient spinecho studies of molecular diffusion. Prog NMR Spectrosc 1987; 19:1-45.
25. Gibbs SJ, Johnson Jr CS. A PFG NMR experiment for accurate diffusion and flow studies in the presence of eddy currents. J Magn Reson 1991; 93:395-402.
26. 1H NMR spectroscopy of biological fluids. Anal Chem 1996; 68:3370-3376.
27. 1H diffusion-edited total correlation NMR spectroscopy (DETOCSY). Anal Chem 1997; 69:1504-1509.
28. 1H NMR spectroscopy of human blood plasma. Prog NMR Spectrosc 1995; 27:475-554.
29. 1H NMR spectra of human blood plasma. Magn Reson Med 1991; 21:222-232.
30. 1H NMR lineshape fitting analyses and biochemical lipid analyses of the lipoprotein fractions VLDL, LDL and HDL, and total human blood plasma. NMR in Biomed 1993; 6:225-233.
31. 1H NMR-based absolute quantitation of human lipoproteins and their lipid contents directly from plasma. J Lipid Res 1994; 35:2292-2304.
32. 1H spectra of lipoproteins. Magn Reson Med 1994; 31:347-358.
33. 31P NMR signals using the variable projection method and prior knowledge. Magn Reson Med 1988; 6:92-98.
34. 1H NMR data from human blood plasma. J Magn Reson B 1995; 106:191-194.
35. Ohsaka A, Yoshikawa K, Matuhasi T. Detection by proton nuclear magnetic resonance of elevated lac-tate concentration in serums from patients with malignant tumors. Japan J Med Sci Biol 1979; 32:305-309.
36. Fossel ET, Carr JM, McDonagh J. Detection of malignant tumors. Water-suppressed proton nuclear magnetic resonance spectroscopy of plasma. New Engl J Med 1986; 315;1369-1376.
37. Verdery RB, Benham DF, McLennan I, Busby MJ, Wehrle JP, Glickson JD. Proton nuclear magnetic resonance methyl and methylene linewidths from plasma decrease during postprandial lipemia. Biochim Biophys Acta 1989; 1006:287-290.
38. Engan T, Krane J, Klepp O, Kvinnsland S. Proton nuclear magnetic resonance spectroscopy of plasma from healthy subjects and patients with cancer. New Engl J Med 1990; 322:949-953.
39. Hiltunen Y, Ala-Korpela M, Jokisaari J, Eskelinen S, Kiviniitty K. Proton nuclear magnetic resonance lineshape studies on human blood plasma lipids from newborn infants, healthy adults, and adults with cancer. Magn Reson Med 1992; 26:89-99.
40. Herring FG, Phillips PS, Pritchard H, Silver H, Whittal KP. The proton NMR of blood plasma and the test for cancer. Mag Reson Med 1990; 48:35-48.
41. Kriat M, Vion-Dury J, Confort-Gouny S, Favre R, Viout P, Sciaky M, Sari H, Cozzone PJ. Analysis of plasma lipids by NMR spectroscopy - applications to modifications induced by malignant tumors. J Lipid Res 1993; 34:1009-1019.
42. Eugene M, Le Moyec L, de Certaines JD, Desruennes M, Le Rumeur E, Fraysse JB, Cabrol C. Lipoproteins in heart transplantation: proton magnetic resonance spectroscopy of plasma. Magn Reson Med 1991; 18:93-101.
43. Pont H, Vion-Dury J, Kriat M, Mouly-Bandini A, Sciaky M, Viout P, Confort-Gouny S, Messana T, Goudart M, Monties JR, Cozzone PJ. NMR spectroscopy of plasma during acute rejection of transplanted hearts. The Lancet 1991; 337:792-793.
44. 1H NMR spectroscopic study of serums from patients with malaria. Physiological Chem and Phys and Med NMR 1988; 20:269-271.
45. Holmes E, Foxall PJD, Nicholson JK. Proton NMR analysis of plasma from renal failure patients: evaluation of sample preparation and spectral-editing methods. J Pharm Biomed Anal 1990; 8:955-958.
46. Bell JD, Lee JA, Sadler PJ, Wilkie DR, Woodham RH. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta 1991; 109:101-107.
47. 1H NMR spectroscopy of human blood plasma. J Pharm Biomed Anal 1993; 11:267-276.
48. Foxall PJD. High resolution NMR spectroscopic investigations into renal allograft function. Ph.D. thesis, University of London, 1993.
49. 1H spin echo NMR. FEBS Letters 1977; 82:12-16.
50. 1H NMR methods for the noninvasive study of metabolism and other processes involving small molecules in intact erythrocytes. J Biochem Biophys Methods 1984; 9:277-306.
51. 1H NMR spectroscopy. Anal Biochem 1982; 121:423-432.
52. Brindle KM, Brown FF, Campbell ID, Grathwol C, Kuchel PW. Application of spin-echo nuclear magnetic resonance to whole-cell systems. Membrane transport. Biochem J 1979; 180:37-44.
53. Kuchel PW, Hunt GE, Johnson GFS, Beilharz GR, Chapman BE, Jones AJ, Singh BS. Lithium, red blood cell choline and clinical state. A prospective study in manic-depressive patients. J Affective Disorders 1984; 6:83-94.
54. Lennon AJ, Scott NR, Chapman BE, Kuchel PW. Hemoglobin affinity for 2,3-bisphosphoglycerate in solutions and intact erythrocytes: studies using pulsed-field gradient nuclear magnetic resonance and Monte Carlo simulations. Biophys J 1994; 67:2096-2109.
55. Kuchel PW, Coy A, Stilbs P. NMR "diffusion-diffraction" of water revealing alignment of erythrocytes in a magnetic field and their dimensions and membrane transport characteristics. Magn Reson Med 1997; 37:637-643.
56. Torres AM, Michniewicz RJ, Chapman BE, Young GA, Kuchel PW. Characterisation of erythrocyte shapes and sizes by NMR diffusion-diffraction of water: correlations with electron micrographs. Magn Reson Imaging 1998; 16:423-434.
57. 1H MAS NMR spectroscopy. Magn Reson Med 1997; 38:334-336.
58. 2 relaxation process. Magn Reson Med 1987; 4:461-470.
59. Foxall PJD, Bewley S, Neild GH, Rodeck CH, Nicholson JK. Analysis of fetal and neonatal urine using proton nuclear magnetic resonance spectroscopy. Arch Dis Child Fetal Neonatal Ed 1995; 73:F153-7.
60. 1H NMR studies of urine during fasting: excretion of ketone bodies and acetylcarnitine. Magn Reson Med 1986; 3:849-856.
61. 1H FT NMR spectrometry. Eur J Pediatr 1986; 145:260-266.
62. Foxall PJD, Mellotte GJ, Bending MR, Lindon JC, Nicholson JK. NMR spectroscopy as a novel approach to the monitoring of renal transplant function. Kidney Int 1993; 43:234-245.
63. Le Moyec L, Pruna A, Eugene M, Bedrossian J, Idatte JM, Huneau JF, Tomé D. Proton nuclear magnetic resonance spectroscopy of urine and plasma in renal transplantation follow-up. Nephron 1993; 65:433-439.
64. Gartland KPR, Beddell CR, Lindon JC, Nicholson JK. The application of pattern recognition methods to the analysis and classification of toxicological data derived from proton NMR spectroscopy of urine. Mol Pharmacol 1991; 39:629-642.
65. 1H NMR spectra of urine. A nonlinear mapping approach to the classification of toxicological data. NMR in Biomed 1990; 3:166-172.
66. 1H NMR and clinical chemical data for classification of nephrotoxicity. J Pharm Biomed Anal 1990; 8:963-968.
67. Anthony ML, Sweatman BC, Beddell CR, Lindon JC, Nicholson JK. Pattern recognition classification of the site of nephrotoxicity based on metabolic data derived from proton nuclear magnetic resonance spectra of urine. Mol Pharmacol 1994; 46:199-211.
68. Holmes E, Bonner FW, Sweatman BC, Lindon JC, Beddell CR, Rahr E, Nicholson JK. NMR spectroscopy and pattern recognition analysis of the biochemical processes associated with the progression and recovery from nephrotoxic lesions in the rat induced by mercury(II)chloride and 2-bromoethanamine. Mol Pharmacol 1992; 42:922-930.
69. 1H NMR spectra of urine using an artificial neural network. J Pharm Biomed Anal 1995; 13:205-211.
70. Tranter GE, Holmes E, Nicholls AW, Nicholson JK, Connelly JC. Metabonomic prediction of drug toxicity via probabilistic neural network analysis of NMR biofluid data. Abstr 9th North American ISSX Meeting, 24-28 October, 1999, p 246.
71. Beckwith-Hall BM, Nicholson JK, Nicholls AW, Foxall PJD, Lindon JC, Connor SC, Abdi M, Connelly J, Holmes E. Nuclear magnetic spectroscopic and principal components analysis investigations into biochemical effects of three model hepatotoxins. Chem Res Tox 1998; 11:260-272.
72. Holmes E, Nicholls AW, Lindon JC, Ramos S, Spraul M, Neidig P, Connor SC, Connelly J, Damment SJP, Haselden J, Nicholson JK. Development of a model for classification of toxin-induced lesions using H NMR spectroscopy of urine combined with pattern recognition. NMR in Biomed 1998; 11:235-244.
73. Holmes E, Nicholson JK, Nicholls AW, Lindon JC, Connor SC, Polley S, Connelly J. The identification of novel biomarkers of renal toxicity using automatic data reduction techniques and PCA of proton NMR spectra of urine. Chemomet & Intel Lab Systems. 1998; 44:245-255.
74. Spraul M, Neidig P, Klauck U, Kessler P, Holmes E, Nicholson JK, Sweatman BC, Salman SR, Beddell CR, Farrant RD, Lindon JC. Automatic reduction of NMR spectroscopic data for statistical and pattern recognition classification of samples. J Pharm Biomed Anal 1994; 12:1215-1225.
75. 1H NMR spectra of human urine from normal and pathological states. Anal Biochem 1994; 220:284-296.
76. Bales JR, Higham DP, Howe I, Nicholson JK, Sadler PJ. Use of high resolution proton nuclear magnetic resonance spectroscopy for rapid multicomponent analysis of urine. Clin Chem 1984; 30:426-432.
77. 1H NMR spectroscopy of human cerebrospinal fluid: Effects of sample manipulation and assignment of resonances. J Pharm Biomed Anal 1993; 11:651-664.
78. Ghauri FYK, Nicholson JK, Sweatman BC, Beddell CR, Lindon JC. NMR spectroscopy of human post mortem CSF: distinction of Alzheimer's disease from controls using pattern recognition and statistics. NMR in Biomed 1993; 6:163-167.
79. Lynch MJ, Masters J, Pryor JP, Lindon JC, Spraul M, Foxall PJD, Nicholson JK. Ultra high field NMR spectroscopic studies on human seminal fluid, seminal vesicle and prostatic secretions. J Pharm Biomed Anal 1994; 12:5-19.
80. 1H NMR spectroscopy for assignment of endogenous metabolite resonances in biofluids. J Pharm Biomed Anal 1994; 12:613-619.
81. 1H NMR spectroscopic studies on dynamic biochemical processes in incubated human seminal fluid samples. Biochim Biophys Acta 1998; 1379:367-380.
82. Powell JJ, Gartland KPR, Lombard M, Sallie R, Nicholson JK, Thompson RPH. Proton nmr spectroscopy of bile as a marker of liver function in liver-transplant patients. Clin Sci 1990; 78:13.
83. Nelson TR, Gillies RJ, Powell DA, Schrader MC, Manchester DK, Pretorius DH. High resolution proton NMR spectroscopy of human amniotic fluid. Prenatal Diagnosis 1987; 7:363-372.
84. 1H nuclear magnetic resonance investigation of synovial fluid components in osteoarthritis, rheumatoid arthritis and traumatic effusions. Br J Rheumatol 1989; 28:23-27.
85. Grootveld MC, Herz H, Haywood R, Hawkes GE, Naughton D, Perera A, Knappitt J, Blake DR, Claxson AWD. Multicomponent analysis of radiolytic products in human body fluids using high field proton nuclear magnetic resonance (NMR) spectroscopy. Radiat Phys Chem 1994; 43:445-453.
86. Parkes HG, Allen RE, Furst A, Blake DR, Grootveld M. Speciation of non-transferrin-bound iron ions in synovial fluid from patients with rheumatoid arthritis by proton nuclear magnetic resonance spectroscopy. J Pharm Biomed Anal 1991; 9:29-32.
87. 1H NMR spectroscopy. J Pharm Biomed Anal 1991; 9:75-82.
88. 13C NMR investigation of synovial fluids. Magn Reson Med 1993; 30:236-240.
89. 1H NMR spectroscopy. Exp Eye Res 1986; 42:357-362.
90. 1H NMR of human saliva. An application of NMR spectroscopy in forensic science. Forensic SCi Int 1987; 34:189-195.
91. •). Free Rad Res 1997: 26:209-234.
92. Powell JJ, Gartland KPR, Nicholson JK, Ainley CC, Thompson RPH. Bile, pancreatic juice and small bowel secretions contain endogenous metal binding ligands. Gut 1990; 31:A1197.
93. Foxall PJD, Price RG, Jones JK, Neild GH, Thompson FD, Nicholson JK. High resolution proton magnetic resonance spectroscopy of cyst fluids from patients with polycystic kidney disease. Biochim Biophys Acta 1992; 1138:305-314.